Acquisition Opportunity MPS Medical was acquired by Innova Medical Group, signaling potential cross-sell opportunities for infusion therapy sets, IV admix products, and related accessories to a broader hospital network and newly integrated distribution channels.

Safety and Quality Emphasize patient and caregiver safety in product messaging to align with hospital standards and quality initiatives, presenting MPS Medical’s high-quality, safety-focused IV therapy solutions as preferred options for infection control and adverse reaction reduction.

Market Fit Target hospital systems and home care providers seeking specialty infusion products with a mid-market revenue profile and scalable manufacturing, leveraging MPS Medical’s FDA-registered status and domestic/international production history.

Digital Engagement Leverage the existing tech stack (WordPress, WooCommerce, AWS) to coordinate digital outreach, e-commerce enablement for devices and accessories, and streamlined procurement conversations with hospital purchasers.

Growth Indicators With a revenue range of one to ten million and a lean team, there is appetite for strategic partnerships, co-development, or exclusive distribution deals to accelerate growth within infusion therapy and pharmacy admixture product lines.